Bo Yang | Cardiovascular Disease | Best Researcher Award 2025

Prof. Bo Yang | Cardiovascular Disease | Best Researcher Award

Wenzhou Medical University | China

Author Profile

Scopus

Google Scholar 

Early Academic Pursuits

Dr. Bo Yang began his academic journey with a strong foundation in the field of nutrition and health sciences. He pursued his doctoral degree at Zhejiang University through a collaborative international research program with Harvard University. This early exposure to global academic environments enabled him to acquire a multidisciplinary perspective and laid the groundwork for his career in nutritional science and lipid medicine. His academic training emphasized both molecular-level investigation and broader public health perspectives, bridging basic research with applied health outcomes.

Professional Endeavors

Following his doctoral studies, Dr. Yang expanded his expertise through postdoctoral training at China Medical University in Taiwan. These experiences enriched his understanding of advanced methodologies in nutrition and health research. He later joined Wenzhou Medical University, where he currently serves as a Research Professor and Director of the Institute of Lipids Medicine. In this leadership role, Dr. Yang oversees both research and academic development, guiding projects that integrate basic, clinical, and translational research approaches.

Contributions And Research Focus

Dr. Yang’s research centers on nutritional epidemiology, functional lipids, and health management. His work explores the role of lipid metabolism and bioactive compounds in mind-body health, with a special emphasis on how dietary interventions influence chronic disease prevention. By integrating molecular nutrition with population-based approaches, his research addresses pressing public health challenges while providing evidence for precision nutrition strategies. His expertise spans functional lipids, mind-body health, and diet-related interventions, making significant contributions to the field of nutritional sciences.

Impact And Influence

With an extensive body of published work in peer-reviewed scientific journals, Dr. Yang has established himself as a recognized voice in the field of nutrition and lipid research. His contributions include more than fifty publications in SCI-indexed journals. Beyond his own research, he actively serves as a peer reviewer for prestigious journals such as Brain, Behavior & Immunity, Food & Function, and Nutrients. His editorial role as Statistical Editor for the British Journal of Nutrition further demonstrates his influence in shaping scientific communication and ensuring methodological rigor in nutrition science.

Academic Cites

Dr. Yang’s publications have been widely cited by scholars and researchers across the globe. His contributions to nutritional epidemiology and lipid metabolism have provided reference points for emerging research in functional foods, mind-body health, and chronic disease prevention. By bridging laboratory findings with population-based studies, his work is frequently referenced in both clinical nutrition and public health research, enhancing the academic discourse in these fields.

Legacy And Future Contributions

Dr. Yang’s legacy lies in his integration of molecular nutrition with population-based health studies, offering a holistic approach to understanding the role of diet in human health. His leadership at the Institute of Lipids Medicine positions him to continue fostering innovation in nutritional research and health management. Future contributions are expected to expand into precision nutrition, functional food development, and preventive strategies for chronic diseases, influencing both academic research and public health policy.

Conclusion

Dr. Bo Yang exemplifies the qualities of an accomplished researcher and academic leader in nutritional science and lipid medicine. His career demonstrates a commitment to advancing scientific knowledge, mentoring future scholars, and addressing global health challenges through nutrition-focused solutions. With his proven track record of impactful research, editorial leadership, and international collaboration, Dr. Yang is poised to make enduring contributions to the fields of nutrition, health, and medicine.

Notable Publications

"Effect of Clostridium butyricum against Microglia‐Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate"

Authors: Jing Sun, Jingxuan Xu, Bo Yang, Keyang Chen, Yu Kong, Na Fang, Tianyu Gong, Fangyan Wang, Zongxin Ling, Jiaming Liu
Journal: Molecular nutrition & food research
Year: 2020

"Effects of low-fat compared with high-fat diet on cardiometabolic indicators in people with overweight and obesity without overt metabolic disturbance: a systematic review and meta-analysis of randomised controlled trials"

Authors: Mengqing Lu, Yi Wan, Bo Yang, Catherine E Huggins, Duo Li
Journal: British Journal of Nutrition
Year: 2018

"Effects of vegetarian diets on blood lipids: a systematic review and meta‐analysis of randomized controlled trials"

Authors: Fenglei Wang, Jusheng Zheng, Bo Yang, Jiajing Jiang, Yuanqing Fu, Duo Li
Journal: Journal of the American Heart Association
Year: 2015

"Ratio of n-3/n-6 PUFAs and risk of breast cancer: a meta-analysis of 274135 adult females from 11 independent prospective studies"

Authors: Bo Yang, Xiao-Li Ren, Yuan-Qin Fu, Jin-Long Gao, Duo Li
Journal: BMC cancer
Year: 2014

 

Yao An | Thrombosis | Best Researcher Award

Mr. Yao An | Thrombosis | Best Researcher Award

Yingqiang Du | Myocardial Infarction | Best Researcher Award

Dr. Yingqiang Du | Myocardial Infarction | Best Researcher Award

Dr. Yingqiang Du, Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University; Suzhou Municipal Hospital; Gusu School, Nanjing Medical University, China

Dr. Yingqiang Du is a renowned cardiology researcher at The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University, China. His research focuses on myocardial infarction and ischemic heart disease, exploring inflammation, fibrosis, metabolic remodeling, and novel therapeutic strategies. As the first or corresponding author of multiple high-impact publications, he has significantly contributed to cardiovascular medicine. His work bridges basic and clinical research, influencing treatment advancements and patient care. With ongoing projects funded by prestigious grants, Dr. Du continues to drive innovation in cardiology, shaping the future of cardiovascular health research.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

📚 EARLY ACADEMIC PURSUITS:

Dr. Yingqiang Du began his academic journey with a strong foundation in medical sciences, focusing on cardiology and cardiovascular research. His early education provided him with a deep understanding of human physiology, pathology, and the complexities of ischemic heart disease. With a keen interest in myocardial infarction and its underlying mechanisms, he pursued specialized training and research, laying the groundwork for his future contributions to the field.

🏥 PROFESSIONAL ENDEAVORS:

Currently, Dr. Du is affiliated with The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University. As a researcher and academic professional, he has taken on significant responsibilities in both clinical and experimental cardiology. His work bridges the gap between theoretical research and practical applications, ensuring that scientific findings translate into improved patient care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Dr. Du’s research primarily centers on myocardial infarction and ischemic heart disease. His studies delve into various aspects, including:

  • The role of inflammation and fibrosis in cardiovascular conditions.
  • The impact of environmental factors, such as micro(nano)plastics, on heart disease.
  • Novel therapeutic approaches involving bioactive compounds like resveratrol and muscone.
  • The involvement of metabolic remodeling and inflammasome activation in aging cells. His extensive work provides crucial insights into the prevention, diagnosis, and treatment of cardiac disorders.

🌟 IMPACT AND INFLUENCE:

Dr. Du’s research has had a profound impact on the field of cardiology. His studies have contributed to a better understanding of the molecular mechanisms of myocardial infarction and fibrosis, paving the way for new treatment modalities. His findings have influenced clinical practices and have been referenced in various medical and scientific discussions worldwide.

📖 ACADEMIC CITES:

As an established researcher, Dr. Du has authored multiple high-impact publications in reputed journals, including:

  • Journal of Hazardous Materials
  • Clinical and Translational Medicine
  • Experimental and Therapeutic Medicine
  • Bioengineered
  • American Journal of Translational Research These publications, where he serves as either the first or corresponding author, reflect his credibility and expertise in the field. His work has been widely cited by peers, demonstrating its relevance and significance.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Du’s contributions to cardiology are paving the way for future breakthroughs in cardiovascular medicine. His research findings are not only enhancing current medical knowledge but also inspiring upcoming researchers to explore novel therapeutic strategies. Moving forward, his work is expected to contribute significantly to:

  • The development of innovative drug treatments for myocardial infarction.
  • The formulation of preventive measures against ischemic heart disease.
  • The exploration of new molecular pathways for better cardiovascular health. His ongoing commitment to research excellence ensures that his legacy will continue to shape the future of cardiology.

🌍CONCLUSION:

Dr. Yingqiang Du is a distinguished researcher whose groundbreaking contributions to cardiology have significantly advanced the understanding of myocardial infarction and ischemic heart disease. His extensive studies on inflammation, fibrosis, and metabolic remodeling have influenced both clinical practices and future research directions. With multiple high-impact publications and ongoing projects, his work continues to shape modern cardiovascular medicine.

TOP NOTABLE PUBLICATION

Title:  Exposure to polyethylene terephthalate micro(nano)plastics exacerbates inflammation and fibrosis after myocardial infarction by reprogramming the gut and lung microbiota and metabolome

Authors: X., Gu, Xin, Z., Zhang, Zhixuan, L., Zhao, Lin, X., Wang, Xiaoyan, Y., Du, Yingqiang

Journal:  Journal of Hazardous Materials

Year: 2025

xie zhengxing | Cardiovascular Disease | Best Research Article Award

Prof. xie zhengxing | Cardiovascular Disease | Best Research Article Award 

Sara Kaveh | Hypercholesterolemia | Best Researcher Award

Ms. Sara Kaveh | Hypercholesterolemia | Best Researcher Award

Ms. Sara Kaveh, Tehran University of Medical Sciences, Iran

Ms. Sara Kaveh is a dedicated researcher and academic affiliated with Tehran University of Medical Sciences, Iran. Her work focuses on advancing medical research and education within the field of health sciences. She has contributed to various projects aimed at improving healthcare outcomes and is recognized for her commitment to scientific excellence and innovation.

Profile:
Education:

Ms. Sara Kaveh is a PhD candidate in Health Economics at Tehran University of Medical Sciences, where her dissertation explores regionalization models for pancreaticoduodenectomy in Iran, focusing on outcomes and costs. She earned her M.Sc. in Health Technology Assessment from Iran University of Medical Sciences, with a dissertation comparing bevacizumab and its combination with erlotinib for metastatic colorectal cancer. Earlier, she completed an M.Sc. in Health Information Technology at Kerman University of Medical Sciences, investigating the use of the Internet for health information among academic professionals. Her work integrates health economics and technology assessment to enhance healthcare delivery and policy.

Professional  Experience:

 

Ms. Sara Kaveh is currently a Research Assistant at Shiraz University of Medical Sciences, a role she began in November 2023, building on her previous tenure at the same institution from August 2019 to August 2021. From June 2017 to August 2019, she worked as an independent researcher, leading multidisciplinary teams and publishing extensively in high-impact journals. Her research spans health economics and technology assessment, contributing significantly to the academic and practical understanding of healthcare improvements.

Honors and Awards:

Ms. Sara Kaveh achieved notable academic distinctions, securing 4th place in the highly competitive Ph.D. entrance exam in Iran and 6th place in the M.Sc. entrance exam. These rankings underscore her exceptional academic capabilities and commitment to excellence in her field of health economics and technology assessment.

Top Notable Publications:

Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review

Journal: Current Therapeutic Research

Date: September 2024

DOI: 10.1016/j.curtheres.2024.100758

Telehealth impact on biomedical, psychosocial, and behavioural outcomes in patients with diabetes older than 50 years: A systematic synthesis without meta-analysis

Journal: Journal of Telemedicine and Telecare

Date: February 2024

DOI: 10.1177/1357633X211052222

Clinical Characteristics, Laboratory Features, and Outcomes of 151 Pediatric Patients with COVID-19 and MIS-C: A Single-center Study in the Northwest of Iran

Journal: Archives of Pediatric Infectious Diseases

Date: May 7, 2023

DOI: 10.5812/pedinfect-132819

Mobile Health-Based Interventions in Self-care and Treatment Adherence in Older People: A Review Study

Journal: International Journal of Aging

Date: April 27, 2023

DOI: 10.34172/ija.2023.e6

Prevention of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2021

DOI: 10.1007/S11096-020-01146-6

WOSUID: WOS:000568149400001

Comparing cardiac troponin levels using sevoflurane and isoflurane in patients undergoing cardiac surgery: a systematic review and meta-analysis

Journal: Journal of Cardiovascular and Thoracic Research

Date: February 12, 2020

DOI: 10.34172/jcvtr.2020.01

Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis

Journal: Clinical Rheumatology

Date: 2020

DOI: 10.1007/S10067-020-04948-1

WOSUID: WOS:000531129700001

Bevacizumab and erlotinib versus bevacizumab for colorectal cancer treatment: systematic review and meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2019

DOI: 10.1007/S11096-018-0754-1

WOSUID: WOS:000458652000008

Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis

Journal: International Journal of Clinical Pharmacy

Date: 2019

DOI: 10.1007/S11096-018-00778-Z

WOSUID: WOS:000458652000007

Health technology assessment of Bevacizumab compare with combination of Bevacizumab with Erlotinib for treatment of patients with metastatic colorectal cancer

DOI: 10.22037/IPA.V1I1.20015

The Efficacy of Ivabradine versus Beta Blockers in Comparison of Atenolol and Metoprolol in Patients with Mitral Stenosis in Sinus Rhythm: A Systematic Review and Meta-Analysis

DOI: 10.22037/IPA.V1I1.20006

Sherin Mehani | Cardiac Rehabilitation | Best Researcher Award

Prof. Sherin Mehani | Cardiac Rehabilitation | Best Researcher Award

Prof. Sherin Mehani, beni-suef university, Egypt

Dr. Sherin Mehani is a distinguished researcher in the field of cardiac rehabilitation with over two decades of expertise in cardiovascular health. Her groundbreaking work focuses on developing and implementing innovative rehabilitation strategies to enhance patient outcomes and quality of life. Dr. Mehani’s research has significantly advanced the understanding of cardiac recovery processes, leading to improved therapeutic protocols and patient care standards. Her dedication to clinical excellence and research has earned her the prestigious Best Researcher Award, recognizing her exceptional contributions to the field of cardiac rehabilitation.

Profile:
Education:

Dr. Sherin Mehani has a distinguished academic background in physical therapy. She earned her Bachelor of Science in Physical Therapy from Cairo University in May 1996, graduating with honors and a Very Good degree. She continued her education at Cairo University, completing her Master of Science in Physical Therapy in 2003 with an Excellent degree, ranking first in her class with a score of 89%. Her master’s thesis focused on the effects of aerobic training on symptomatic mitral valve prolapse in females. Dr. Mehani pursued further specialization with a Ph.D. in Physical Therapy from Cairo University, awarded in 2007 with an Excellent degree and a score of 94%, again ranking first. Her doctoral research examined the role of aerobic training in patients with symptomatic idiopathic dilated cardiomyopathy. She achieved her Assistant Professor degree in Physical Therapy in 2012, with a Very Good rating of 99 points, and was promoted to Professor in 2018, with an exceptional rating of 99.3 points.

 

Professional Experience:

Dr. Sherin Mehani has enjoyed a distinguished career in physical therapy, marked by both academic excellence and administrative leadership. She began her professional journey as an Administrator at the Faculty of Physical Therapy, Cairo University, from 1997 to May 2003, focusing on cardiovascular-respiratory disorders and geriatrics. She then progressed to Assistant Lecturer from May 2003 to October 2007, and subsequently served as a Lecturer in cardiac rehabilitation from November 2007 to November 2012. In 2012, she was promoted to Assistant Professor at Cairo University, where she remained until 2015.

In August 2015, Dr. Mehani transitioned to Beni-Suef University, taking on various important roles, including Assistant Professor in the Physical Therapy Department for Internal Medicine. From March 2012 to 2021, she also served as Vice Dean for Education and Student Affairs. Since 2021, she has been the Dean of the Faculty of Physical Therapy at Beni-Suef University, where she continues to contribute significantly to both the field of physical therapy and academic administration.

 

Activities:

Dr. Sherin Mehani has made significant contributions to the field of physical therapy through a range of roles and initiatives. From 2008 to 2012, she actively participated in Cairo University’s quality and accreditation plans as a faculty committee member and served as the secretary of the Graduate Studies and Research Committee. She was responsible for overseeing the laboratory for lung function and cardiopulmonary efficiency, supporting both academic research and clinical evaluations. Additionally, Dr. Mehani managed the pulmonary function testing and cardiopulmonary exercise testing lab at Cairo University.

Her commitment to education is evident through her creation of an e-learning course on cardiac rehabilitation for third-year students from 2009 to 2015 and her involvement in developing curricula for various courses, including exercise physiology and cardiopulmonary physical therapy. Dr. Mehani played a pivotal role in establishing student laboratories and outpatient clinics at Beni Suef University and organized the first student conference on modern electrical therapy techniques.

Dr. Mehani also supervised the Physical Therapy Studies Department at the National Institute for Science and Studies of the Elderly, preparing and overseeing numerous research plans. Her contributions extend to developing the research plan for the College of Physical Therapy and preparing postgraduate courses at Beni Suef University. She has taught various courses at both Cairo and Beni Suef Universities and supervised approximately fifty master’s and doctoral theses, covering topics such as aerobic training, cardiac rehabilitation, and the impact of various therapies on health outcomes. Her extensive involvement underscores her dedication to advancing physical therapy through research, teaching, and administration.

Top Notable Publications:

 

Mehani, S.H.M., Helmy, Z.M., Adel, W., & Mohamed, M.I. (2024). Revealing the role of high-intensity interval training combined with inspiratory muscle training on atrial fibrillation associated with chronic heart failure: Is there a shift towards anti-remodelling adaptation? European Journal of Preventive Cardiology, 31(11), 1420–1424. [DOI or URL if available]

Mohammed, M., Mehani, S., Aziz, A.A., Mohamed, M.F., & Nahas, N.E. (2023). Erratum: Efficacy of threshold inspiratory muscle trainer versus diaphragmatic plus pursed lip breathing in occupational COPD. Beni-Suef University Journal of Basic and Applied Sciences, 12(1), 92. [DOI or URL if available]

Mohammed, M., Hassan, S., Aziz, A.A., Mohamed, M.F., & El Nahas, N. (2023). Efficacy of threshold inspiratory muscle trainer versus diaphragmatic plus pursed lip breathing in occupational COPD. Beni-Suef University Journal of Basic and Applied Sciences, 12(1), 73. [DOI or URL if available]

Elhamrawy, M.Y., Mohamed, S., Bahnasy, W., Elkholy, A., & Said, M. (2021). Effect of vestibular rehabilitation therapy on spatio-temporal gait parameters in elderly patients with post-stroke hemineglect. Advances in Rehabilitation, 35(3), 17–24. [DOI or URL if available]

Helmy, Z.M., Mehani, S.H.M., El-Refaey, B.H., Al-Salam, E.H.A., & Felaya, E.-S.E.E.-S. (2019). Low-level laser therapy versus trunk stabilization exercises on sternotomy healing after coronary artery bypass grafting: A randomized clinical trial. Lasers in Medical Science, 34(6), 1115–1124. [DOI or URL if available]

Mehani, S.H.M. (2018). Novel molecular biomarkers’ response to a cardiac rehabilitation programme in patients with ischaemic heart diseases. European Journal of Physiotherapy, 20(4), 235–243. [DOI or URL if available]

Mehani, S.H.M. (2017). Comparative study of two different respiratory training protocols in elderly patients with chronic obstructive pulmonary disease. Clinical Interventions in Aging, 12, 1705–1715. [DOI or URL if available]

Mehani, S.H.M. (2017). Cardiopulmonary rehabilitation program impact on prognostic markers in selected patients with resting and exercise-induced ventilatory inefficiency: A clinical trial. Journal of Physical Therapy Science, 29(10), 1803–1810. [DOI or URL if available]

Mehani, S.H.M. (2017). Immunomodulatory effects of two different physical therapy modalities in patients with chronic obstructive pulmonary disease. Journal of Physical Therapy Science, 29(9), 1527–1533. [DOI or URL if available]

Mehani, S.H.M. (2013). Correlation between changes in diastolic dysfunction and health-related quality of life after cardiac rehabilitation program in dilated cardiomyopathy. Journal of Advanced Research, 4(2), 189–200. [DOI or URL if available]